journal article·2023-12

Potentiating the Systemic Immunity by Bacteria‐Delivered Sting Activation in a Tumor Microenvironment

Wenfei Chen, Yining Zhu, Jiahao Chen, Xiandan Jing, Yimin Xiong, Ling Zou, Jiahui Li, Qinhui Liu, Yanping Li, Yuan Huang, Jinhan He

Advanced Functional Materials· Volume 33· Issue 52
Publisher page

Abstract

Abstract Stimulator of interferon genes (STING) connects the innate immunity to potent adaptive immunity via multiple pathways, which play a critical role in cancer treatment. Clinical application of STING agonists is mainly restrained due to the metabolic instability caused by intrinsic cyclic dinucleotide ligands. Previously, an orally available non‐nucleotide human STING agonist, MSA‐2 is presented, and to further improve its therapeutic efficacy, this work leverages the nonpathogenic Escherichia coli Nissle 1917 for tumor‐targeted delivery of the STING agonist by coating biocompatible polydopamine on the bacterial surface, termed as PDMN. The engineered bacterial delivery platform holds potential in elevating levels of type I interferon (IFN) along with proinflammatory cytokines and inducing maturation on dendritic cells. Intravenous administration of PDMN with laser irradiation to the tumor region promotes IFN‐β expression in a tumor microenvironment and mounts both the innate and adaptive immune responses, leading to profound regressions of established melanoma and hepatocellular carcinoma in mice. By synergized with anti‐PD‐1 therapy, a substantial long‐lived protective immunity is generated, capable of preventing distant tumor metastases. Hence, this study identifies a STING‐amplified biotherapy to shape the cell‐mediated antitumor immunity, serving as a potential personalized cancer vaccine with enhanced biosafety and immune activation profile for diverse applications.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: interferon and immune responses · Immunotherapy and Immune Responses · Virus-based gene therapy research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmacy Institute of Metabolic Diseases and Pharmacotherapy West China Hospital Sichuan University Chengdu Sichuan Province 610041 China

Department of Biomedical Engineering Johns Hopkins University School of Medicine Baltimore MD 21218 USA

Key Laboratory of Drug‐Targeting and Drug Delivery System of the Education Ministry and Sichuan Province Sichuan Engineering Laboratory for Plant‐Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology West China School of Pharmacy Sichuan University Chengdu Sichuan Province 610041 China

Funding

Fundamental Research Funds for the Central Universities · Postdoctoral Research Foundation of China · Sichuan Province Science and Technology Support Program · National Natural Science Foundation of China

References (66)

Show source-provided references
1. 10.3390/cancers1311269510.3390/cancers13112695 ↗
2. 10.1038/s41467-020-16602-010.1038/s41467-020-16602-0 ↗
3. 10.1002/adma.20220991010.1002/adma.202209910 ↗
4. 10.1080/2162402X.2015.108863110.1080/2162402X.2015.1088631 ↗
5. 10.3390/ijms1802040410.3390/ijms18020404 ↗
6. 10.3390/ijms23231450410.3390/ijms232314504 ↗
7. 10.1038/nature0731710.1038/nature07317 ↗
8. 10.1016/j.cell.2021.09.01910.1016/j.cell.2021.09.019 ↗
9. 10.1126/science.abb425510.1126/science.abb4255 ↗
10. 10.1126/science.abc662210.1126/science.abc6622 ↗
11. 10.1038/s41586-019-1553-010.1038/s41586-019-1553-0 ↗
12. 10.1073/pnas.162136311410.1073/pnas.1621363114 ↗
13. 10.1038/s41467-019-09221-x10.1038/s41467-019-09221-x ↗
14. 10.1007/s00018-022-04219-z10.1007/s00018-022-04219-z ↗
15. 10.1016/j.celrep.2015.04.03110.1016/j.celrep.2015.04.031 ↗
16. 10.1016/j.celrep.2018.11.04710.1016/j.celrep.2018.11.047 ↗
17. 10.1038/s41565-021-00962-910.1038/s41565-021-00962-9 ↗
18. 10.1002/adtp.20200013010.1002/adtp.202000130 ↗
19. 10.1038/s41565-018-0342-510.1038/s41565-018-0342-5 ↗
20. 10.1016/j.jconrel.2020.11.01710.1016/j.jconrel.2020.11.017 ↗
21. 10.1126/science.aba609810.1126/science.aba6098 ↗
22. 10.1016/j.biomaterials.2022.12187110.1016/j.biomaterials.2022.121871 ↗
23. 10.1073/pnas.220271911910.1073/pnas.2202719119 ↗
24. 10.1126/science.aac425510.1126/science.aac4255 ↗
25. 10.1016/j.addr.2022.11436310.1016/j.addr.2022.114363 ↗
26. 10.1016/j.addr.2022.11444410.1016/j.addr.2022.114444 ↗
27. 10.1016/j.addr.2022.11429610.1016/j.addr.2022.114296 ↗
28. 10.1126/sciadv.abo616310.1126/sciadv.abo6163 ↗
29. 10.1038/s41467-021-26956-810.1038/s41467-021-26956-8 ↗
30. 10.1016/j.addr.2022.11436410.1016/j.addr.2022.114364 ↗
31. 10.1038/s41587-022-01244-y10.1038/s41587-022-01244-y ↗
32. 10.1002/adma.20221094910.1002/adma.202210949 ↗
33. 10.1126/scitranslmed.aau797510.1126/scitranslmed.aau7975 ↗
34. 10.1002/advs.20180058110.1002/advs.201800581 ↗
35. 10.1002/adfm.20220848610.1002/adfm.202208486 ↗
36. 10.1002/adma.20220595010.1002/adma.202205950 ↗
37. 10.1126/scitranslmed.abc281610.1126/scitranslmed.abc2816 ↗
38. 10.1021/acsnano.8b0223510.1021/acsnano.8b02235 ↗
39. 10.1002/adfm.20190662310.1002/adfm.201906623 ↗
40. 10.7150/thno.3757410.7150/thno.37574 ↗
41. 10.1038/s41577-019-0210-z10.1038/s41577-019-0210-z ↗
42. 10.1158/0008-5472.CAN-20-299010.1158/0008-5472.CAN-20-2990 ↗
43. 10.1016/j.apsb.2020.12.01810.1016/j.apsb.2020.12.018 ↗
44. 10.1038/s41467-019-13204-310.1038/s41467-019-13204-3 ↗
45. 10.1016/j.immuni.2020.06.00910.1016/j.immuni.2020.06.009 ↗
46. 10.1016/j.immuni.2008.09.00310.1016/j.immuni.2008.09.003 ↗
47. 10.1016/j.apsb.2020.03.00110.1016/j.apsb.2020.03.001 ↗
48. 10.1016/j.immuni.2019.03.02510.1016/j.immuni.2019.03.025 ↗
49. 10.1016/j.nantod.2021.10113910.1016/j.nantod.2021.101139 ↗
50. 10.1016/j.jconrel.2017.10.04110.1016/j.jconrel.2017.10.041 ↗
51. 10.1016/j.immuni.2022.12.00210.1016/j.immuni.2022.12.002 ↗
52. 10.1186/s12967-022-03444-110.1186/s12967-022-03444-1 ↗
53. 10.1002/adma.20221094910.1002/adma.202210949 ↗
54. 10.1073/pnas.211100311910.1073/pnas.2111003119 ↗
55. 10.1016/j.immuni.2014.10.01910.1016/j.immuni.2014.10.019 ↗
56. 10.1021/acs.nanolett.9b0409410.1021/acs.nanolett.9b04094 ↗
57. 10.1186/s13045-022-01363-810.1186/s13045-022-01363-8 ↗
58. 10.1126/scitranslmed.aaz660610.1126/scitranslmed.aaz6606 ↗
59. 10.1126/sciimmunol.abn661210.1126/sciimmunol.abn6612 ↗
60. 10.1002/advs.20170010910.1002/advs.201700109 ↗
61. 10.1038/s41586-020-2719-510.1038/s41586-020-2719-5 ↗
62. 10.1016/bs.ircmb.2019.06.00110.1016/bs.ircmb.2019.06.001 ↗
63. 10.1186/s12943-020-01250-110.1186/s12943-020-01250-1 ↗
64. 10.1126/science.123245810.1126/science.1232458 ↗
65. 10.1016/j.celrep.2020.10838110.1016/j.celrep.2020.108381 ↗
66. 10.1021/acsnano.3c0036310.1021/acsnano.3c00363 ↗